• TaqI Restriction Endonuclease Protocol

  2026-09-09

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific digestion of plasmid DNA, PCR products, and genomic DNA for cloning and molecular biology workflows. It is intended for research use, not diagnostic or medical applications, and should be applied with the supplier’s specified reaction conditions.

• Hexetidine: From MIC to Oral Biofilm Evidence

  2026-09-09

  Hexetidine (NSC-17764) is a broad-spectrum oral antimicrobial whose value depends on matching concentration, exposure, and endpoint to the research question. This evidence-calibrated guide connects strain-specific MIC data, biofilm inhibition assays, and clinical plaque and gingivitis findings without treating them as interchangeable.

• JC-1 and the DRP1 Death Axis in ATC

  2026-09-08

  A mechanism-led guide to using JC-1 in anaplastic thyroid carcinoma research, connecting mitochondrial membrane potential with the JAK1/2–STAT3–DRP1 pathway, apoptosis, pyroptosis, and translational assay design.

• GRE Combination and CREB/MITF Control of Melanogenesis

  2026-09-08

  The reference study evaluates a combination of glabridin, resveratrol, and ellagic acid (GRE) across melanogenesis, oxidative-stress, and inflammatory cell assays. Its main contribution is to connect reduced melanin and tyrosinase activity with suppression of CREB phosphorylation and MITF-associated gene and protein expression, while also identifying antioxidant and nitric oxide-related effects.

• Podophyllotoxin (N1790) for Reliable Cell Assays

  2026-09-07

  This scenario-based guide shows how Podophyllotoxin, SKU N1790, can support reproducible cell-viability, cell-cycle, apoptosis, and autophagy workflows. It connects formulation data with practical assay design and distinguishes direct product evidence from comparative hepatocellular carcinoma findings.

• Gut Dysbiosis, Docetaxel Resistance, and Prostate Cancer

  2026-09-07

  Zhong et al. connect antibiotic-associated gut dysbiosis with prostate cancer progression and Docetaxel resistance through increased intestinal permeability, intratumoral lipopolysaccharide, and NF-κB-IL6-STAT3 signaling. Their combined mouse, cell, microbiome, and patient analyses identify Proteobacteria enrichment as a candidate marker of advanced disease while defining important limits for clinical translation.

• Cell Counting Kit-8 Plus in Senolytic Research

  2026-09-05

  Mechanistic senolytic studies require more than a viability number. This thought-leadership guide shows how Cell Counting Kit-8 (CCK-8) Plus can strengthen Tubeimoside I research while clarifying the biological limits of WST-8 readouts.

• Carbapenemase Gene Transmission in CREC Hospitals

  2026-09-04

  Chen et al. characterized carbapenemase-encoding genes, resistance phenotypes, plasmid transfer, mobile genetic elements, and strain relatedness in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The study’s main contribution is its integrated view of gene location and dissemination, showing that blaNDM-1 was common, frequently plasmid-associated, and readily transferable in laboratory conjugation experiments.

• DiR Imaging for MSC Mechanism in PND

  2026-09-04

  A translational framework for using DiR (DiIC 18 (7)) to connect hUC-MSC biodistribution with the β-NGF–STMN2/NMNAT2–SARM1/NF-κB biology of perioperative neurocognitive disorders.

• GSK 2837808A LDHA Inhibition Workflow

  2026-09-03

  GSK 2837808A is a selective LDHA tool for separating lactate production from broader glycolytic activity in cancer-cell assays. This workflow connects hepatocellular carcinoma research with carefully bounded, hypothesis-generating studies of lactate-linked immune signaling in colorectal cancer.

• Cardamomin, Oxidative Damage, and Ischemic Stroke

  2026-09-03

  This study links cardamomin from Amomum villosum Lour. with protection against hydrogen peroxide-induced oxidative injury in BV-2 cells and cerebral ischemic damage in rats. Its central contribution is a mechanism-based model involving MEK/ERK-dependent NRF2 activation, suppression of oxeiptosis, and reduction of AIFM1-associated parthanatos, supported by complementary cellular and tissue assays.

• DDM and Membrane Protein Conformational Control

  2026-09-02

  Discover how n-Dodecyl-β-D-maltoside (DDM) can be used not only for membrane protein solubilization, but also for preserving conformational populations during integrin and cryo-EM studies. This article connects detergent selection with the structural interpretation of dynamic membrane protein assays.

• Hexa His Tag Peptide: IP Workflow Guide

  2026-09-02

  The Hexa His tag peptide enables competitive, antibody-free recovery of 6X His fusion proteins from anti-His immunoprecipitation workflows. This guide explains practical elution conditions, controls, troubleshooting, and how to protect downstream protein interaction analysis from antibody-chain contamination.

• Dual Recombinase Tracing and Mouse Neo-Oogenesis

  2026-09-01

  Xie, Zhou, and Zheng use complementary Cre-loxP and Dre-rox lineage labels to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and busulfan-induced injury, the study finds no labeled growing oocytes or metaphase II eggs arising from non-pre-existing ovarian cells, strengthening the case against in vivo postnatal neo-oogenesis.

• BAPTA-AM Workflows for Calcium Signaling and I/R Assays

  2026-09-01

  BAPTA-AM gives researchers a practical way to separate intracellular Ca²⁺ effects from caspase-driven injury, channel activity, and oxidative stress. This workflow-focused guide covers cardiomyocyte ischemia/reperfusion models, apoptosis assays, calcium imaging, neuroprotection studies, and troubleshooting confounders.

8046 records 1/537 page Next 12345 下5页 Last page